Urolog. pro Praxi, 2008; 9(1): 21-23

Testosterone supplementation therapy in testicular cancer patients

prof. MUDr. Dalibor Ondruš DrSc1, RNDr. PhDr. Martina Ondrušová2
1 Onkologická klinika LF UK, Onkologický ústav sv. Alžbety, Bratislava
2 Národný onkologický register SR, NOÚ, Bratislava

Improved survival of testicular cancer patients during the last years leads to rising of interest on the adverse disease consequences of whole the organism. Not only the tumor alone, but also its treatment (mainly radiotherapy or chemotherapy) may have impact on patient‘s hormonal status. The aim of this study was to assign the claim of hormonal profile examination into algorithm of follow-up not only in patients with bilateral disease, but also in patients with unilateral testicular tumor.

Keywords: testicular cancer, androgen deficiency, supplementation therapy

Published: April 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ondruš D, Ondrušová M. Testosterone supplementation therapy in testicular cancer patients. Urol. praxi. 2008;9(1):21-23.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Huddart RA, Norman A, Moynihan C, Horwich A, Parker C, Nicholls E, Dearnaley DP. Fertility, gonadal and sexual function in survivors of testicular cancer. Br J Cancer 2005; 93: 200-207. Go to original source... Go to PubMed...
    2. Lackner JE, Múrk I, Schatzl G, Marberger M, Kratzik C. Hypogonadism and androgen deficiency symptoms in testicular cancer survivors. Urology 2007; 69: 754-758. Go to original source... Go to PubMed...
    3. Marenčák J. Je susbstitúcia testosterónu potenciálnym rizikom pre prostatickú žľazu u stárnuceho muža? Urol List 2007; 5: 46-53.
    4. Nord C, Bjoro T, Elingsen D et al. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. Eur Urol 2003; 44: 322-328. Go to original source... Go to PubMed...
    5. Nuver J, Smit AJ, Wolffenbuttel HR, Sluiter WJ, Hoekstra HJ, Sleijfer DT, Gietema JA. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol 2005; 23: 3718-3725. Go to original source... Go to PubMed...
    6. Ondruš D, Špániková B, Ondrušová M, Mardiak J. Testosterone deficiency and bone metabolism damage in testicular cancer survivors. Urology 2007; 70 (Suppl. 3A): 166 (abstr. MP-21. 18). Go to original source...
    7. Tubaro A. Testosterone and prostate cancer. 2007; 51: 293-295.
    8. Veselský Z. Význam substituce androgeny u mužů s testikulární hypofunkci. Urolog. pro Praxi 2003; 4: 236-238.
    9. Von Eckardstein S, Nieschlag E. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: A phase II study. J Androl 2002; 23: 419-425. Go to PubMed...
    10. Wang C. Challenges in the diagnosis of the right patient for testosterone replacement therapy. Eur Urol Suppl 2007; 6: 862-867. Go to original source...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.